Insilico Medicine vs Scale AI
Relationship
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
Aligned comparison
Capability overlap
Shared · 3
Not verified for Scale AI · 5
Recorded for Insilico Medicine. Scale AI’s product records say nothing either way — a missing record is not a missing capability.
Not verified for Insilico Medicine · 1
Recorded for Scale AI. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
Insilico Medicine
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Scale AI
Platform
AI platform for defence and intelligence users, for searching, summarising and reasoning over operational data.
Platform for building and evaluating enterprise generative-AI applications against a customer's own data.
No counterpart
Insilico Medicine sells these in a stack layer with no product recorded for Scale AI yet — nothing on the other side to compare them against.
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
Scale AI sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
Data service
Data labelling and curation service producing training and evaluation sets for AI models.